AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2015

Feb 25, 2015

30339_dirs_2015-02-25_1a6aaad7-99a3-458c-bbf4-2a7546fcedea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-02-17

Reporting Person: Ryan Christopher G (President, PPS, Americas)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-17	Stock Option (Right to Buy)	$51.5300	A	10244.0000	Acquired	2025-02-17	Common Stock (10244.0000)	Direct
2015-02-17	Stock Option (Right to Buy)	$51.5300	A	5120.0000	Acquired	2025-02-17	Common Stock (5120.0000)	Direct

Footnotes

F1: Stock Option term is 10 years. 2,561 options or 25% vested on 02/17/15, 25% will vest on 02/17/2016, 25% will vest on 2/17/2017, and 25% will vest on 2/17/2017.

F2: Stock Option term is 10 years. 2,560 options or 50% vested on 02/17/15. 25% will vest on 02/17/2016 and 25% will vest on 2/17/2017.